Compare NBY & VIRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | NBY | VIRT |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Bankers/Brokers/Service |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 398.2M | 2.9B |
| IPO Year | 2007 | 2015 |
| Metric | NBY | VIRT |
|---|---|---|
| Price | $4.63 | $34.10 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $41.43 |
| AVG Volume (30 Days) | ★ 2.3M | 881.5K |
| Earning Date | 11-07-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 2.81% |
| EPS Growth | N/A | ★ 132.69 |
| EPS | 0.47 | ★ 4.62 |
| Revenue | $10,302,000.00 | ★ $2,694,104,000.00 |
| Revenue This Year | $23.91 | N/A |
| Revenue Next Year | $32.05 | N/A |
| P/E Ratio | $188.45 | ★ $7.39 |
| Revenue Growth | ★ 390.34 | 41.05 |
| 52 Week Low | $0.46 | $31.89 |
| 52 Week High | $6.47 | $45.77 |
| Indicator | NBY | VIRT |
|---|---|---|
| Relative Strength Index (RSI) | 69.99 | 49.85 |
| Support Level | $4.37 | $33.08 |
| Resistance Level | $6.47 | $34.52 |
| Average True Range (ATR) | 0.88 | 0.78 |
| MACD | 0.20 | -0.01 |
| Stochastic Oscillator | 64.69 | 41.42 |
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.